Rheumatoid Arthritis Increases Mortality Risk in Staphylococcus aureus Infections
Prospective cohort study examines clinical characteristics and outcomes of S aureus bacteremia in patients with rheumatoid arthritis.
Prospective cohort study examines clinical characteristics and outcomes of S aureus bacteremia in patients with rheumatoid arthritis.
Long-term tenofovir treatment for hepatitis B infection is linked with abnormal phosphorus metabolism in a recent study.
Study examined patients who received infliximab for rheumatologic conditions and the incidence of postoperative infections.
The TNF inhibitor shows lower risk for infections and tuberculosis, according to a recent study.
End-stage renal disease is 5-fold more likely to develop in patients with 3 or more infection-related hospitalizations versus none.
A review and analysis of registry data from patients with RA indicates that changing from rituximab to another class of biologic agent does not alter the subsequent risk of infection.
In the first study simultaneously evaluating sepsis and sepsis-related mortality in RA patients with serious infection, researchers found that any bDMARD exposure significantly lowered mortality rates.
The use of biologic agents in treatment of patients rheumatoid arthritis or psoriasis is associated with a significant risk of heptatis B flares.